Latest pharmaceutical news and updates from Switzerland. AI-curated articles covering pharmaceutical topics.
Swiss pharma companies maintain steady export levels to Russia, citing patient care responsibilities while facing criticism over continued trade.
Swiss pharmaceutical giant announces positive results from phase III trials combining giredestrant and everolimus treatments, showing significant improvement in patient survival rates.
Swiss pharmaceutical giant announces significant progress in phase III clinical trials combining giredestrant and everolimus treatments
Swiss pharmaceutical giant Novartis reports successful Phase III trials for Ianalumab therapy, potentially offering the first targeted treatment for Sjögren's Syndrome patients worldwide.
Former BeiGene relocates headquarters from Cayman Islands to Basel, joining Swiss pharma hub and planning expansion of its cancer research operations.
Swiss pharmaceutical giant Novartis makes strategic move into longevity research through partnership with BioAge Labs, marking significant investment in aging-related drug development.
Swiss pharmaceutical companies face market uncertainty as US President Trump announces imminent executive order targeting prescription drug prices, potentially affecting Swiss pharma profits.
Swiss pharmaceutical giant Roche commits to massive five-year investment in US operations, including new production facilities and creation of 12,000 jobs.
Swiss pharmaceutical giant Roche receives European Commission approval for Columvi, marking a significant breakthrough in lymphoma treatment options.
Investigation reveals the hidden environmental impact of Switzerland's pharmaceutical industry despite green initiatives
Basel-based Roche announces strategic partnership with Zealand Pharma to develop weekly injectable obesity treatment, marking major expansion into weight management market.
Major shareholder announces significant sale of shares as part of strategic portfolio diversification
UBS study warns of Swiss pharmaceutical sector's vulnerability to potential US tariffs, with possible long-term implications for research and production locations.
Swiss medicines regulator takes legal action against media houses over alleged unauthorized advertising of weight-loss drugs Ozempic and Wegovy.
Swiss pharmaceutical giant Novartis announces closure of recently acquired German biotech firm Morphosys by end of 2025, impacting hundreds of positions.
Swiss pharmaceutical giant Novartis announces closure of recently acquired German biotech firm Morphosys by 2025, impacting 330 jobs and raising questions about pharmaceutical industry consolidation.
From trusted Swiss news outlets